Author

S. Hehlgans

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:gene regulatory network inference· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

F. Roedel· 2 shared A. Crider· 1 shared A. Moroni· 1 shared A. Nist· 1 shared A. S. Haydo· 1 shared B. Jakob· 1 shared B. Linder· 1 shared B. Roth· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiophysics

F. Roedel

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BRAT1 - a new therapeutic target for glioblastoma

A. S. Haydo, J. H. Schmidt, A. Crider, T. Kögler, J. Ertl, S. Hehlgans, M. E. Hoffmann, R. Rathore, O. Güllülü, Y. Wang, X. Zhang, C. Herold-Mende, F. Pampaloni, I. Tegeder, I. Dikic, , B. Linder

This study identifies BRAT1 as a key driver of glioblastoma growth and invasion, showing that its inhibition with CurD reduces tumor migration and enhances radiation sensitivity.

bioRxiv · Jul 8, 2024Cancer Biology

X-ray Irradiation activates immune response in human T-lymphocytes by eliciting a Ca2+ signaling cascade

G. Thiel, D. H. Tandl, T. Sponagel, S. Fuck, T. Smit, S. Hehlgans, B. Jakob, C. Fournier, F. Roedel, B. Roth, A. Moroni

The paper shows X-ray irradiation triggers a Ca2+ signaling cascade in T-lymphocytes, leading to immune activation through NFAT nuclear translocation.

bioRxiv · Nov 13, 2020Biophysics

Drug-adapted cancer cell lines reveal drug-induced heterogeneity and enable the identification of biomarker candidates for the acquired resistance setting

M. Michaelis, M. N. Wass, I. Reddin, Y. Voges, F. Rothweiler, S. Hehlgans, J. Cinatl, M. Mernberger, A. Nist, T. Stiewe, F. Roedel, J. Cinatl

The paper investigates drug-induced heterogeneity in cancer cell lines and identifies biomarkers for acquired resistance to YM155.

bioRxiv · Feb 13, 2020Pharmacology & Toxicology